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Recent HIV infection or divergent HIV or simian
immunodeficiency virus (SIV) strains may be responsible
for Western blot–indeterminate results on 70 serum sam-
ples from Zairian hospital employees that were reactive in
an enzyme immunoassay. Using universal polymerase
chain reaction HIV-1, HIV-2, and SIV primers, we detected
1 (1.4%) HIV-1 sequence. Except for 1 sample, no molec-
ular evidence for unusual HIV- or SIV-like strains in this
sampling was found. 
H
IV-1 and HIV-2 are believed to be the result of cross-
species transmission from simian immunodeficiency
virus (SIV)–infected chimpanzees and sooty mangabeys,
respectively, which represent 2 (SIVcpz and SIVsm) of the
6 major lentiviral phylogenetic lineages (1,2). No evidence
exists that SIV strains from the remaining nonhuman pri-
mate lineages have infected humans, although many grow
in human cells in vitro as do SIVcpz and SIVsm (3). Since
humans are exposed to a plethora of primate lentiviruses
through blood or body fluids during hunting, butchering,
eating bushmeat, and keeping primates as pets (3), the
potential exists for zoonotic transmission of diverse pri-
mate lentiviruses in many parts of sub-Saharan Africa,
including the Congo River basin (4). This potential is sup-
ported by the identification of a Cameroonian man whose
HIV serologic results were indeterminate but whose serum
specimen reacted strongly and exclusively with an
SIVmnd V3 loop peptide (5). An even more compelling
case for cross-species exposure is the recent finding of a
Cameroonian man who may have been exposed to a
colobus SIV, as indicated by a strong humoral (env IDR
and V3) and a weak cellular (gag) immune response (6).
Although SIV sequences were not identified in either case,
the findings suggest that humans are probably exposed to
different simian retroviruses that can establish new infec-
tions in humans (3). 
Nonhuman primates infected with SIV from the cur-
rently recognized lineages can harbor antibodies that sero-
logically cross-react with some HIV-1 or HIV-2 antigens
(3). In many cases, HIVWestern blots (WBs) with indeter-
minate profiles of SIV-infected monkeys resemble those of
HIV enzyme immunoassay (EIA)–positive, WB-indeter-
minate human sera from Africa. In general, such indeter-
minate African sera demonstrate a broad range of
reactivity to HIV-1 proteins, in contrast to predominant
p24 reactivity in WB-indeterminate sera from persons in
the United States (7–9). These data suggest that the WB-
indeterminate patterns in HIV EIA-reactive sera from per-
sons living in Africa may reflect more than just a recent
HIV infection or an infection with a highly divergent HIV-
1 strain (10); they may reflect either cross-reactivity with
unknown pathogens of African origin or exposure to new
HIV- or SIV-like strains. 
The Study
We investigated the presence of HIV or SIV in 70 HIV
EIA-reactive, WB-indeterminate serum specimens collect-
ed in 1984 and 1986 from employees of Mama Yemo
Hospital in Kinshasa, Zaire (currently the Democratic
Republic of Congo) (11). WB bands were identified by
using an HIV-1/2 WB assay (version 2.2, Genelabs
Diagnostics, Singapore) and classified as indeterminate
according to criteria for interpreting HIV-1 (http://www.
cdc.gov/mmwr/preview/mmwrhtml/00001431.htm).
Briefly, a positive WB result indicates reactivity to at least
p24 and 1 of the 3 env (gp41, gp120, or gp160) proteins
with banding intensity at least as strong as that seen in the
weak-positive control; a negative WB result indicates no
reactivity and an indeterminate WB result indicates reac-
tivity to at least 1 protein. 
Of the 70 WB-indeterminate serum specimens, 69
showed a broad range of HIV-1 WB-indeterminate band
patterns, and 1 had an HIV-2 WB-indeterminate pattern
with weak reactivity against gp36, p68, and gp80 proteins.
Analysis of HIV-1 WB-indeterminate patterns provided
several important observations. First, most of the speci-
mens (41/69, 59%) showed reactivity to multiple viral pro-
teins (Figure), whereas the remaining specimens (28/69,
41%) demonstrated reactivity against single HIV-1 pro-
teins, including p24 (13/69, 18.8%), p17 (n = 8, 11.6%),
gp160w (w = weak) (n = 4, 5.8%), and p51, p66, and
gp41w (n = 1 each; 1.4% each). Second, in all but 3 spec-
imens the WB-indeterminate patterns with reactivity to
multiple viral proteins combined proteins of p24 or p17
gag or both with others, giving the following 21 profiles:
p17/p24 (14/69, 20.3%); p24/p66 and p17/p24/p66 (n = 3
each, 4.3% each); p24/p51, p17/p24/p51, and p17/p24/
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gp160, p24/p51/gp41w, p17/p51/p66, p17/p31/gp41w,
p24/p51/p55, p24/p51/p66, p17/p24/p51/p66, p17/p24/
p51/p55, p17/p24/p55/p66, p24/p31/p51/ p55, p31/p66,
p51/gp41w, and p31/p66/gp41w (n = 1 each, 1.4% each).
Overall, this analysis indicated reactivity to 8 HIV-1 pro-
teins that occurred as single bands or multiple combina-
tions. Whereas reactivity to p24 might represent either
early infection with HIV or reaction to nonspecific anti-
gens (8), reactivity to other HIV-1 proteins (p17, p31, p51,
p55, p66, gp41, or gp160) could reflect at least exposure to
HIV-1, HIV-2, or SIV variants as well as cross-reactivity
with yet unidentified HIV- or SIV-like strains (3,10).  
To determine whether HIV- and SIV-like RNAcould be
detected in the 70 WB-indeterminate specimens, we
attempted reverse transcription–polymerase chain reaction
(RT-PCR) amplification of HIV-1, HIV-2, and SIV.
However, because of a small volume (≤300 µL) of some
serum specimens, a limited number of primers was used.
We selected 4 sets of primers for 3 highly conserved gene
regions, including env-gp41, pol protease, and pol inte-
grase, which we previously developed and extensively
tested for the efficient PCR amplification of field speci-
mens. Briefly, gp41 primers allow the amplification of
HIV-1 groups M (subtypes A–K and U [unclassifiable]) N,
and O and SIVcpz with an efficiency of 95% (13); HIV-1
type specific protease primers efficiently (>95%) detect
group M viruses (subtypes A–K and U [unclassifiable]),
and allow successful amplification of some PCR–gp41
negative specimens. HIV-2 type-specific protease primers
allow the amplification of HIV-2 at least subtypes Aand B
(13), and HIV-2/SIV integrase primers amplify HIV-2 and
at least 5 major SIV lineages including SIVcpz, SIVsm,
SIVagm (African green monkey), SIVmndBK12 (man-
drill), and SIVsyk (Sykes monkey) (14). The integrase
primers should also amplify other SIV lineages including
SIVcol, SIVLhoest/SIVsun, SIVgsn, SIVmus, SIVmon,
SIVtal, and SIVdeb (3). This prediction is based on the fact
that genetic diversity of these sequences within the 3′-end
of primer regions was the same as in strains previously
used for testing (15), which was clearly visible through
DNA alignment of the integrase primers with all SIV
genomic integrase sequences deposited in GenBank.
Positive controls for PCR amplification included HIV-1
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Figure. A) Distribution of HIV-1 Western blot–indeterminate patterns among 69 serum specimens from Kinshasa, Zaire, reactive by
enzyme immunoassay. B) Phylogenetic classification of HIV-1 protease sequence ZA30972 (GenBank accession no. AY562558) isolat-
ed from the p17 gag-reactive serum. The phylogenetic tree was generated by the neighbor-joining method with the nucleotide distance
calculated by Kimura 2-parameter method (12), included in the GeneStudio package (http://www.genestudio.com). Reference sequences
were obtained from the Los Alamos database (http://hiv-web.lanl.gov/MAP/hivmap.html). The position of the outgroup (Simian immuno-
deficiency virus [SIV]cpz) is not shown. Values on branches represent the percentage of 100 bootstrap replicates. The scale bar indi-
cates an evolutionary distance of 0.10 nucleotides per position in the sequence.Mn, HIV-2 ROD, and SIVsm. Using this approach, we
amplified a 297-bp HIV-1 protease (PR) gene from only 1
(1.4%) of the 70 serum specimens. The remaining 69 spec-
imens were PCR negative for all the primers tested.
Phylogenetic analysis of the PR gene sequence showed a
close phylogenetic relationship with the HIV-1 MALstrain
(Figure), a recombinant virus that contains portions of sub-
types A and D and an unclassifiable region that was iden-
tified in 1985 in Zaire (16). 
Conclusions
The PR gene sequence was identified in the serum of
the person with reactivity to only the p17 gag band by WB,
which suggests that this person was recently infected and
that antibodies to all the HIV-1 antigens had not yet devel-
oped. No information was available on demography, risk,
or clinical status of this person. In the remaining 69 WB-
indeterminate specimens, we could not rule out exposure
to SIV from nonhuman primates, from handling infected
animal meat before consuming it, or from keeping mon-
keys as pets. Although the limited molecular scope of this
study and the quality of the old serum specimens may not
be adequate for molecular confirmation of such viruses,
our findings of complex HIV WB-indeterminate patterns
with reactivity to multiple viral proteins in serum speci-
mens from persons living in the Democratic Republic of
Congo provide comprehensive insights into HIV WB-
indeterminate sera in the mid-1980s. 
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